Johnson & Johnson在宾夕法尼亚州投资1B美元建造一个细胞治疗厂, 创造了4500个工作岗位, Johnson & Johnson invests $1B in Pennsylvania to build a cell therapy plant, creating 4,500 jobs, part of a broader U.S. push for domestic advanced medicine manufacturing.

Johnson & Johnson宣布投资10亿美元在宾夕法尼亚州下格维内德建造一个细胞治疗制造设施, 创造超过4,000个建筑工作岗位和500个永久性生物制造职位。 Johnson & Johnson announced a $1 billion investment to build a cell therapy manufacturing facility in Lower Gwynedd, Pennsylvania, creating over 4,000 construction jobs and 500 permanent biomanufacturing positions. 该项目是到2029年更广泛的550亿美元的美国投资计划的一部分,旨在扩大癌症、免疫紊乱和神经疾病的先进疗法的生产。 The project, part of a broader $55 billion U.S. investment plan by 2029, aims to expand production of advanced therapies for cancer, immune disorders, and neurological diseases. 该设施预计将于2031年开业,得到4 150万美元的州奖励支助,并随后在宾夕法尼亚州进行类似的大规模制药投资。 The facility, expected to open by 2031, is supported by $41.5 million in state incentives and follows similar large-scale pharmaceutical investments in Pennsylvania. 这一举动与美国鼓励国内制造业的关税政策有关,因为J&J已经在州内运营10个设施,雇用数千人。 The move is linked to U.S. tariff policies encouraging domestic manufacturing, with J&J already operating 10 facilities in the state and employing thousands.